Provided by Tiger Trade Technology Pte. Ltd.

Ascendis Pharma A/S

264.34
+4.091.57%
Volume:176.50K
Turnover:46.29M
Market Cap:17.50B
PE:20.40
High:267.91
Open:261.39
Low:257.52
Close:260.25
52wk High:282.15
52wk Low:186.05
Shares:66.19M
Float Shares:65.54M
Volume Ratio:0.67
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):12.96
EPS(LYR):-4.4176
ROE:118.78%
ROA:9.58%
PB:10.51
PE(LYR):-59.84

Loading ...

Ascendis Pharma Share Conversion Reshapes Access And Liquidity On Nasdaq

Simply Wall St.
·
Apr 15

European Equities Traded in the US as ADRs Rise in Tuesday Trading

MT Newswires Live
·
Apr 14

How Investors May Respond To Ascendis Pharma (ASND) Achondroplasia Combo Data And YUVIWEL Launch

Simply Wall St.
·
Apr 11

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Apr 09

Ascendis Pharma Price Target Maintained With a $273.00/Share by Wedbush

Dow Jones
·
Apr 09

Wedbush Reaffirms Their Buy Rating on Ascendis Pharma (ASND)

TIPRANKS
·
Apr 09

Ascendis Pharma to list ordinary shares directly on Nasdaq from April 20

Reuters
·
Apr 09

Ascendis Pharma announces new data from COACH trial

TIPRANKS
·
Apr 08

Ascendis says COACH trial shows TransCon CNP plus hGH boosts arm span in achondroplasia

Reuters
·
Apr 08

European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

MT Newswires Live
·
Apr 07

Ascendis Pharma Gets Orphan Drug Exclusivity for Yuviwel

Dow Jones
·
Apr 07

Ascendis Pharma gets orphan drug exclusivity for Yuviwel, launches in the U.S.

TIPRANKS
·
Apr 07

Analysts Are Bullish on Top Healthcare Stocks: Ascendis Pharma (ASND), Encompass Health (EHC)

TIPRANKS
·
Apr 06

Ascendis Pharma files Form 3 for director Jean-Jacques Bienaime

Reuters
·
Apr 02

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Mar 31

How Investors May Respond To Ascendis Pharma (ASND) Growth‑Disorder Data And New Board Appointment

Simply Wall St.
·
Mar 31

Ascendis Pharma held annual general meeting with 90.16% of shares voted

Reuters
·
Mar 25

European Equities Traded in the US as American Depositary Receipts Climb in Monday Trading

MT Newswires Live
·
Mar 23

Ascendis Pharma A/S EVP and CFO Scott Thomas Smith files initial beneficial ownership statement

Reuters
·
Mar 19

Ascendis Pharma A/S files Form 3 for SVP and PAO Mads Bodenhoff

Reuters
·
Mar 19